TrialInflammatory bowel diseases2026

Serum and Histologic Eosinophilia as a Predictive Biomarker of Response to Mirikizumab in Ulcerative Colitis.

Emily C L Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.